Atlas Trials

Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Clinical trial NCT00416494 · COMPLETED

Trial details

NCT number
NCT00416494
Sponsor
Herbert Hurwitz, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2003-09-01
Primary completion
2008-01-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.